Olema Oncology

Sermonix Pharmaceuticals

This biopharmaceutical company develops oncology products, such as lasofoxifene, for patients with metastatic breast and gynecological cancers.

Galera

This biopharmaceutical company develops small-molecule therapies to reduce the side effects of radiotherapy and improve treatment outcomes for patients with advanced breast cancer.

Avenzo Therapeutics

This biotechnology company develops oncology therapies targeting solid tumours and metastatic breast cancer for patients with high unmet medical needs.

TESARO

This biopharmaceutical company develops and commercialises oncology medicines, including treatments for ovarian and endometrial cancers, for patients undergoing chemotherapy or with specific genetic mutations.

Halda

This biopharmaceutical company develops proximity-targeting small molecule therapies to treat patients with solid tumours including prostate and breast cancers.

Volastra Therapeutics

This clinical-stage biotechnology company develops oncology therapeutics targeting chromosomal instability to treat patients with advanced solid tumours.

Nuvalent

This biopharmaceutical company develops targeted small molecule kinase inhibitors for patients with genomically defined cancers such as non-small cell lung cancer.

Azeria Therapeutics

The company develops small molecule drugs targeting pioneer factors to treat hormone-resistant breast and prostate cancer patients.